• Precirix launches CAM-FAP-Ga-68 Academic Access Program

    Tuesday August 27th 2024

  • Galapagos announces FDA clearance of IND application for Phase 1/2 ATALANTA-1 study of CD19 CAR-T, GLPG5101, in relapsed/refractory non-Hodgkin lymphoma

    Friday August 23rd 2024

  • A potential new oral drug for leishmaniasis has successfully been tested in healthy humans

    Thursday August 22nd 2024

  • Biotalys Named Sustainable Crop Protection Company of the Year

    Wednesday August 21st 2024

  • SwiftPharma and AntoXa to present plant-made anti-ricin antibody technology to NATO expert panel

    Thursday August 15th 2024

  • When faster is not better: New study links premature development of human neurons to brain developmental disorders

    Thursday August 8th 2024

  • Rejuvenate Biomed and SAS tap AI to develop disease-agnostic drug repurposing discovery tools

    Thursday August 1st 2024

  • ACROBiosystems Launches GMP Brand Resilient Supply at ISSCR to Accelerate Cell and Gene Therapy Development

    Thursday August 1st 2024

  • Your news here?

  • Confo Therapeutics Announces EUR 60M Series B Financing to Advance Pipeline of Novel GPCR-Modulating Therapies into Clinical Development

    Friday July 26th 2024

  • Precigen Appoints Phil Tennant as Chief Commercial Officer to Spearhead First Potential Gene Therapy Launch

    Tuesday July 23rd 2024

  • Antonin (Tony) de Fougerolles appointed as new Chair of etherna

    Tuesday July 16th 2024


Strategic Partners